Loading...

Brefeldin A Solution (1,000X)

Pricing & Availability
Regulatory Status
RUO
Other Names
BFA
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420601 1 mL 65 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Brefeldin A (BFA) is a protein transport inhibitor commonly used to enhance intracellular cytokine staining signals by blocking transport processes during cell activation. Especially useful for the intracellular staining of cytokines, BFA leads to the accumulation of most cytokines at the Golgi Complex/Endoplasmic Reticulum (see Jung, et al., 1993). Optimal conditions for use are cell type and time-dependent. Typically, protein transport inhibitors are included during in vitro cell activation cultures for 4-24 hours prior to harvest (see references below for additional information). Brefeldin A Solution is supplied as a 1,000X solution, which should be diluted to 1X in cell culture medium.

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
Brefeldin A Solution is supplied as a 1000X in DMSO, which should be diluted to 1X in cell culture medium.
Concentration
5.0 mg/ml
Storage & Handling
Store the Brefeldin A Solution (1,000X) between 2°C and 8°C. Note: DMSO freezes at this temperature.
Application

ICFC - Quality tested
Recommended Usage

Dilute the 1000X solution to 1X in the tissue culture medium. It is recommended that cells are cultured with brefeldin A for ≤ 24 hours, as this can become toxic for cell viability.

Application Notes

Completely thaw the solution before use, DMSO freezes at 4°C.  We recommend aliquotting the reagent into smaller volumes to avoid repeated freeze-thawing.  

Application References

(PubMed link indicates BioLegend citation)
  1. O'Sullivan BJ, et al. 2006. J. Immunol. 176:7278.
  2. Fuse S, et al. 2007. J. Immunol. 178:5227.
  3. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  4. Redfern CH,et al.2006.J. Clin Oncol.19:3107. PubMed
  5. Smithey MJ, et al. 2008. J. Immunol. 180:3406. PubMed
  6. Elzey BD, et al. 2008. Blood 111:38684. PubMed
  7. Nguyen KD, et al. 2008. J. Immunol. 181:5386. PubMed
  8. Miner MD, et al. 2008. Microb Pathog. 45:273. PubMed
  9. Goodridge HS, et al. 2009. J. Immunol. 182:1146. PubMed
  10. Markey KA, et al. 2009. Blood 113:5644. PubMed
  11. Wilcox RA, et al. 2009. Blood PubMed
  12. Zenaro E, et al. 2009. J. Leukoc Bio. PubMed
  13. Rozkova D, et al. 2009. Clin Immunol. 131:1. PubMed
  14. Butcher JP, et al. 2010. Clin Cancer Res. 16:2065.
  15. Boisvert M, et al. 2010. J. Virol. 84:7782. PubMed
  16. Liu WC, et al. 2010. J. Virol. 84:12011.15. Tawara I, et al. 2011. Clin Cancer Res. 17:77. PubMed
  17. Iwata Y, et al. 2011. Blood. 117:530. PubMed
  18. Schmidt NW, et al. 2011. J. Immunol. 186:3836. PubMed
  19. Langkjaer A, et al. 2012. Clin Immunol. 145:1. PubMed
  20. Molinero LL, et al. 2012. PNAS. 109:18529. PubMed
  21. Li HW, et al. 2012. J. Immunol. 189:5572. PubMed
  22. Wang JM, et al. 2013. J. Virol. 87:4372. PubMed
  23. Fukuoka A, et al. 2013. Int Immunol. 25:373. PubMed
  24. Wang Jm, et al. 2013. J Virol. 87:11626. PubMed
  25. Lee TH, et al. 2013. J Biol Chem. 288:32873. PubMed
  26. Shi L, et al. 2014. J. Immunol. 192:649. PubMed
  27. Bulati M, et al. 2014. Exp Gerontol. PubMed
  28. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  29. Tuna H, et al. 2014. J Leukoc Biol. 95:471. PubMed
  30. Miller ML, et al. 2014. PNAS. 111:7397. PubMed
  31. Wang Y, et al. 2014. Sci Rep. 4:5346. PubMed
  32. Zhou GL, et al. 2014. J Cell Sci. 127:3916. PubMed
  33. Rist MJ, et al. 2015. J Virol. 89:703. PubMed
Product Citations
  1. Yakkala C, et al. 2021. Front Immunol. 12:695150. PubMed
  2. Zheng B, et al. 2021. Int J Mol Sci. 22: . PubMed
  3. Alexander KL, et al. 2021. Gastroenterology. 161:522. PubMed
  4. Trinks N, et al. 2021. Commun Biol. 4:1151. PubMed
  5. Chen J, et al. 2022. Adv Healthc Mater. 11:e2101714. PubMed
  6. Wang R, et al. 2018. Oncoimmunology. 7:e1461303. PubMed
  7. Wang Y, et al. 2014. Sci Rep. 4:5346. PubMed
  8. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  9. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  10. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  11. Xin G, et al. 2021. Cancer Immunol Res. 9:454. PubMed
  12. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  13. Nesterenko PA, et al. 2021. Cell Rep. 37:110167. PubMed
  14. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  15. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  16. Fote GM, et al. 2022. J Cell Sci. 135:. PubMed
  17. Aguilar-Pineda JA, et al. 2021. iScience. 24:102993. PubMed
  18. Moudra A, et al. 2021. J Immunol. 206:2109. PubMed
  19. Zhu S, et al. 2017. Exp Cell Res.. 10.1016/j.yexcr.2017.10.013. PubMed
  20. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  21. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  22. Pablo-Bernal R, et al. 2016. J Gerontol A Biol Sci Med Sci. 71: 610 - 618. PubMed
  23. Tuna H, et al. 2014. J Leukoc Biol. 95:471. PubMed
  24. Weng RR, et al. 2021. Nat Commun. 12:2163. PubMed
  25. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  26. Maschmeyer P, et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.11.005. PubMed
  27. Yamamoto A, et al. 2019. J Clin Invest. 129:3640. PubMed
  28. Shi L, et al. 2014. J Immunol. 192:649. PubMed
  29. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  30. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  31. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  32. Krone A, et al. 2022. Sci Rep. 218:. PubMed
  33. Michaud D, et al. 2022. Front Immunol. 12:745873. PubMed
  34. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  35. Piper CJM, et al. 2020. Cell Reports. 29(7):1878-1892.e7.. PubMed
  36. Gay MD, et al. 2020. Cancer Prev Res (Phila). . PubMed
  37. Just S, et al. 2016. Sci Rep. 6:39796. PubMed
  38. Almshayakhchi R, et al. 2021. Front Oncol. 11:636977. PubMed
  39. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  40. Nguyen K, et al. 2008. J Immunol. 181:5386. PubMed
  41. Wilcox R, et al. 2009. Blood. 114:2936. PubMed
  42. Starnbach X 2015. J Immunol. 195: 1665-1675. PubMed
  43. Garg B, et al. 2016. Mutagenesis. 10.1093/mutage/gew023. PubMed
  44. Ruhland M, et al. 2016. Nat Commun. 7:11762. PubMed
  45. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  46. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  47. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  48. Kang X, et al. 2022. Vaccines (Basel). 10:. PubMed
  49. Jeong J, et al. 2021. Immune Netw. 21:e31. PubMed
  50. Jondle CN, et al. 2021. MBio. 12:. PubMed
  51. Smithey M, et al. 2008. J Immunol. 180:3406. PubMed
  52. Rana A, et al. 2020. Front Immunol. 11:536. PubMed
  53. Dayoub O, et al. 2017. Sci Rep. 10.1038/s41598-017-09933-4. PubMed
  54. Martens A, et al. 2020. Nat Immunol. 21:381. PubMed
  55. Wang Z, et al. 2020. Autophagy. 1:. PubMed
  56. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  57. Hradilova N, et al. 2017. PLoS One. 12(2):e0171539. PubMed
  58. Griffiths K, et al. 2016. Nat Commun. 7:13894. PubMed
  59. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  60. Al-Attar A, et al. 2016. Data Brief. 8: 536-44. PubMed
  61. Gonzalez-Perez G, et al. 2016. J Immunol. 196: 3768 - 3779. PubMed
  62. Pablo-Bernal R, et al. 2015. J Infect Dis. 10.1093/infdis/jiv520. PubMed
  63. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  64. Snyder LM, et al. 2022. Immunohorizons. 6:660. PubMed
  65. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  66. Yu H, et al. 2011. J Leukoc Biol. 90:205. PubMed
  67. Doll K, et al. 2016. J Immunol. 196: 4253 - 4262. PubMed
  68. Liu W, et al. 2016. J Virol. 90: 6085 - 6096. PubMed
  69. Fucikova J, et al. 2016. Blood. 128(26):3113-3124. PubMed
  70. Douthwaite J, et al. 2017. J Immunol. 198(1):528-537. PubMed
  71. Liu W, et al. 2010. J Virol. 84:12011. PubMed
  72. Elzey B, et al. 2008. Blood. 111:3684. PubMed
  73. Ries M, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006506. PubMed
  74. Rialdi A, et al. 2016. Science. 352: aad7993. PubMed
  75. Li H, et al. 2012. J Immunol. 189:5572. PubMed
  76. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  77. Shenoy AT, et al. 2021. Nat Commun. 12:5834. PubMed
  78. Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
  79. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  80. Dumaine JE, et al. 2021. Elife. 10:. PubMed
  81. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  82. Jondle CN, et al. 2021. J Virol. 95:e0072621. PubMed
  83. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  84. Uddin MN, et al. 2022. Brain Behav Immun Health. 26:100563. PubMed
  85. Carissimo G, et al. 2019. Life Sci Alliance. 2:e201900298. PubMed
  86. Wang Y, et al. 2020. Sci Adv. 6:eaba5412. PubMed
  87. Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed
  88. Codo AC, et al. 2020. Cell Metab. 32:437. PubMed
  89. Crooks SD, et al. 2022. Immunohorizons. 6:705. PubMed
  90. Fang E, et al. 2022. MedComm (2020). 3:e117. PubMed
  91. Tawara I, et al. 2011. Clin Cancer Res. 0.761805556. PubMed
  92. Orlov M, et al. 2017. PLoS One.. 10.1371/journal.pone.018296. PubMed
  93. Martins M, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006529. PubMed
  94. Gross C, et al. 2016. Neurol Neuroimmunol Neuroinflamm. 3: e289. PubMed
  95. Krämer B, et al. 2016. PLoS One. 11: 0162068. PubMed
  96. Cao Y, et al. 2018. Nat Commun. 2.940972222. PubMed
  97. Emmer BT, et al. 2018. Elife. 7:e38839. PubMed
  98. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  99. Harty N 2011. J Immunol. 186:3836. PubMed
  100. Iwata Y, et al. 2011. Blood. 117:530. PubMed
  101. Lee T, et al. 2013. J Biol Chem. 288:32873. PubMed
  102. Vigano S, et al. 2015. J Virol. 89: 7829-7840. PubMed
  103. Vacaflores A, et al. 2016. PLoS One. 11: 0157175. PubMed
  104. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  105. Kim J, et al. 2016. Nat Immunol. 17:1159-1166. PubMed
  106. Johnson AM, et al. 2020. J Immunol. 204:2295. PubMed
  107. Buqué A, et al. 2020. Nat Commun. 3.110416667. PubMed
  108. Huang RS, et al. 2021. Curr Protoc. 1:e246. PubMed
  109. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  110. Gao Y, et al. 2022. Immunity. 55:1732. PubMed
  111. Han K, et al. 2021. Nat Metab. 3:318. PubMed
  112. Peng L, et al. 2022. Cell Rep Med. 3:100634. PubMed
  113. Bachy S, et al. 2022. iScience. 25:103758. PubMed
  114. Ohtsuka J, et al. 2021. iScience. Online ahead of print. PubMed
  115. Redfern C, et al. 2006. J Clin Oncol. 24:3107. PubMed
  116. Yan H, et al. 2020. ACS Appl Mater Interfaces. 12:19324. PubMed
  117. Matisz C, et al. 2017. Sci Rep. 7:40631. PubMed
  118. Castro I, et al. 2016. J Virol. 90: 5280 - 5291. PubMed
  119. Zhang W, et al. 2015. Infect Immun . 83: 3213-3223. PubMed
  120. Ji L, et al. 2012. PLoS One. 7:e50909. PubMed
  121. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  122. Grace PS, et al. 2021. Front Immunol. 12:679973. PubMed
  123. Li Y, et al. 2021. Vaccines (Basel). 9:. PubMed
  124. Liu W, et al. 2022. Bio Protoc. 12:e4285. PubMed
  125. Ma K, et al. 2022. iScience. 25:104347. PubMed
  126. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  127. Ngwenyama N, et al. 2019. JCI Insight. 4:e125527. PubMed
  128. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  129. Butchar J, et al. 2010. Clin Cancer Res. 2.100694444. PubMed
  130. Wang J, et al. 2013. J Virol. 87:4372. PubMed
  131. Nice T, et al. 2016. PLoS One. 12: 1005684. PubMed
  132. Pfeifle R, et al. 2016. Nat Immunol. 18:104-113. PubMed
  133. Krishnan A, et al. 2020. Am J Pathol. 190:1284. PubMed
  134. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  135. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  136. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  137. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  138. Stepanova E, et al. 2021. Microorganisms. 9:. PubMed
  139. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  140. Sekine T, et al. 2020. Cell. 183:158. PubMed
  141. Gogokhia L, et al. 2019. Cell Host Microbe. 25:285. PubMed
  142. Guo C, et al. 2018. Immunity. 49:842. PubMed
  143. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  144. Rossato C, et al. 2017. Biologicals. 10.1016/j.biologicals.2017.06.007. PubMed
  145. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  146. Loeuillard E, et al. 2020. J Clin Invest. 130:5380. PubMed
  147. Matsushita T, et al. 2015. Rheumatology. 101093/rumatology/kv331. PubMed
  148. Molinero L, et al. 2012. Proc Natl Acad Sci U S A. 109:18529. PubMed
  149. Tse SW, et al. 2021. Mol Ther. 29:2227. PubMed
  150. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  151. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  152. Rosser EC, et al. 2020. Cell Metabolism. 31(4):837-851. PubMed
  153. Zenaro E, et al. 2009. J Leukoc Biol. 86:1393. PubMed
  154. Goodridge H, et al. 2009. J Immunol. 182:1146. PubMed
  155. Gnerlich J, et al. 2010. J Immunol. 185:4063. PubMed
  156. Boisvert M, et al. 2010. J Virol. 84:7782. PubMed
  157. Langkjær A, et al. 2012. Clin Immunol. 145:1. PubMed
  158. Rozková D, et al. 2009. Clin Immunol. 131:1. PubMed
  159. Miner M, et al. 2008. Microb Pathog. 45:273. PubMed
  160. Miller M, et al. 2014. Proc Natl Acad Sci U S A. 111:7397. PubMed
  161. Gartlan K, et al. 2015. Blood. 126: 1609-1620. PubMed
  162. Ulland T, et al. 2016. Nat Commun. 7:13180. PubMed
  163. Melacarne A, et al. 2021. Cell Reports. 36(1):109312. PubMed
  164. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  165. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  166. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  167. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  168. Li Z, et al. 2021. JCI Insight. 6:. PubMed
  169. Virtakoivu R, et al. 2021. Clin Cancer Res. 27:4205. PubMed
  170. Koschel J, et al. 2021. Cell Death Differ. 28:2257. PubMed
  171. FitzPatrick MEB, et al. 2021. Cell Rep. 34:108661. PubMed
  172. Bass VL, et al. 2021. Mol Syst Biol. 17:e10127. PubMed
  173. Markey K, et al. 2009. Blood. 113:5644. PubMed
  174. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  175. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  176. Theisen U, et al. 2020. J Cell Biol. :219. PubMed
  177. Dáňová K, et al. 2017. J Immunol. 198(2):729-740. PubMed
  178. Beyaz S, et al. 2016. Nat Immunol. 18:184-195. PubMed
  179. Kadivar M, et al. 2016. J Immunol. 197(12):4584-4592. PubMed
  180. Wang J, et al. 2013. J Virol. 87:11262. PubMed
  181. Gussarow D, et al. 2021. Front Med (Lausanne). 8:770381. PubMed
  182. Landi A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.072. PubMed
  183. Fukuoka A, et al. 2013. Int Immunol. 25:373. PubMed
  184. Bulati M, et al. 2014. Exp Gerontol. 54:123. PubMed
  185. Zhou G, et al. 2014. J Cell Sci. 127:3916. PubMed
  186. Rist M, et al. 2015. J Virol. 89:703. PubMed
  187. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  188. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  189. Mohammadpour H, et al. 2020. JCI Insight. 5:00. PubMed
  190. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  191. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  192. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  193. Genardi S, et al. 2020. Front Immunol. 11:610010. PubMed
  194. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  195. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  196. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  197. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  198. Mackroth M, et al. 2016. PLoS Pathog. 12:e1005909. PubMed
  199. Rau M, et al. 2016. J Immunol. 196: 97 - 105. PubMed
  200. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  201. Ruland C, et al. 2017. Brain Behav Immun. 10.1016/j.bbi.2017.06.010. PubMed
  202. Ahmadi H,et al. 2017. Inflammopharmacology. . 10.1007/s10787-017-0410-8. PubMed
  203. Li J, et al. 2018. Redox Biol. 0.976388889. PubMed
  204. Krishna B, et al. 2016. Sci Rep. 6: 24674. PubMed
  205. Schridde A, et al. 2017. Mucosal Immunol. 10.1038/mi.2016.142. PubMed
  206. Wang W, et al. 2020. STAR Protoc. 1:100218. PubMed
  207. Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed
  208. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  209. Carrion B, et al. 2021. Neurol Neuroimmunol Neuroinflamm. 8:. PubMed
  210. Petrova T, et al. 2021. FEBS J. 288:5909. PubMed
  211. Nesterenko PA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  212. Matei DE, et al. 2021. Med (N Y). 2:864. PubMed
  213. Lu G, et al. 2017. PLoS One. 12:e0178352. PubMed
  214. Orozco SL, et al. 2019. Cell Rep. 28:2275. PubMed
  215. Laczkó D, et al. 2020. Immunity. 53:724. PubMed
  216. Abshire C, et al. 2016. PLoS Pathog. 12:e1006088. PubMed
  217. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.
5. Jung T, et al. 1993. J. Immunol. Meth. 159:197.

Gene ID
NA

Related FAQs

The Brefeldin A solution freezes at 4°C . Is the solution still OK?

We recommend to thaw in warm water after removing from the fridge.  The Brefeldin A is dissolved in DMSO, which freezes at 18°C, so this is normal.  No one has reported any problems with the freeze/thaw cycles and this is how we recommend it is stored.   If customers are concerned, they can aliquot the Brefeldin A to avoid the freeze thaw.

How do I choose monensin or Brefeldin A solution?

Generally, Brefeldin A is more toxic for longer term incubations, so for shorter stimulations (6 hrs or less) use Brefeldin A.  For longer stimulations use monensin.  We recommend optimization for each cell type and protocol.

Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account